Market Tracker

12/14 5:15pm ET

Valeant Pharmaceuticals International Inc (NYSE:VRX)

19.68
Delayed Data
As of 4:00pm ET
 -2.37 / -10.75%
Today’s Change
8.31
Today|||52-Week Range
22.81
+35.54%
Year-to-Date
3 Stocks Move on Thursday
2:52pm / GuruFocus News - Paid Partner Content
Cramer: These CEOs Are Creating Value
Dec 12 / TheStreet.com - Paid Partner Content
Valeant (VRX) Touches 52-Week High: Is the Stock Officially Back?
Dec 13 / Zacks.com - Paid Partner Content
Valeant (VRX) in Focus: Stock Moves 11.7% Higher
Dec 11 / Zacks.com - Paid Partner Content
No Two Stocks Are the Same: Cramer's 'Mad Money' Recap (Tuesday 12/12/17)
Dec 12 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close22.05
Today’s open21.05
Day’s range19.01 - 21.70
Volume53,353,795
Average volume (3 months)15,391,349
Market cap$7.7B
Data as of 4:00pm ET, 12/14/2017

Growth & Valuation

Earnings growth (last year)-716.47%
Earnings growth (this year)-30.79%
Earnings growth (next 5 years)-2.00%
Revenue growth (last year)-7.39%
P/E ratio5.0
Price/Sales0.52
Price/Book2.43

Competitors

 Today’s
change
Today’s
% change
GLPGGalapagos NV-1.15-1.34%
CTLTCatalent Inc+0.04+0.10%
ACADACADIA Pharmaceutica...-0.97-3.24%
TAROTaro Pharmaceutical ...-0.81-0.76%
Data as of 4:02pm ET, 12/14/2017

Financials

Next reporting dateMarch 1, 2018
EPS forecast (this quarter)$0.93
Annual revenue (last year)$9.7B
Annual profit (last year)-$2.4B
Net profit margin-24.90%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Joseph C. Papa
Chief Financial Officer &
Executive VP-Finance
Paul S. Herendeen
Corporate headquarters
Laval, Quă©bec

Forecasts